• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
  • Contact Us
WeedWeek

WeedWeek

WeedWeek is the best way to keep up with the green rush

  • Membership
  • My Account
  • LinkedIn
  • Instagram
  • Twitter
  • Politics
  • Money
  • Ops
  • Brands
  • Culture
  • Events

MedMen exits Florida in $83M deal

By Alex Halperin
02/28/2022 11:34 PM GMT-0700
FacebookTweetPin

THE BIG IDEA

Hi all,

MSO Curaleaf has clarified that it isn’t exposed to U.S. sanctions against Russia. It is, however, exposed to U.S. sanctions against cannabis.

Also in today’s newsletter:

  • MedMen exits Florida

Read up,

Alex

Follow us on 

Log in or become a WeedWeek Member to read this article.

Share:
FacebookTweetPin
Filed Under:
Federal

Primary Sidebar

Recent Webinar

Growth in a Tight Market

WeedWeek Wonks: 2025 Wrap-Up & 2026 Outlook

Duration Jan 22 @ 1pm PST
Speakers Elisabeth Stahura, Alex Halperin

RSVP Now

Join WeedWeek California Pro Today!

WeedWeek Pro is the essential news and information resource for California cannabis professionals.

  • Access the Weedweek California Pro Newsletter
  • Access the California Tax and License Maps
  • Steep discounts on job posts in the WeedWeek career center
Sign Up

Get a risk-free 14 day trial for FREE!

Most Read

  • Regulation & Compliance

    EXCLUSIVE: We tested top Calif. prerolls for potency inflation

  • Industry Voices

    Calif. interstate commerce law opens pathway for licensed operators

  • Regulation & Compliance

    Exclusive: Does Stiiizy have a diiiversiiion problem?

Related Articles

See More Federal Articles
hemp
Hemp

Newsbrief: Sen. Rand Paul visits Cornbread hemp

supreme court
Federal

Newsbrief: Supreme Court passes on legalization case

rescheduling
Federal

Cannabiz responds to rescheduling report

Become a member and get access to exclusive content.

Join Now!

Footer

Join WeedWeek Pro

Become A Member Today and Get Access to Exclusive Content. Join here

Follow us

Follow WeedWeek for more content.

  • Instagram
  • LinkedIn
  • Twitter
  • About
  • Privacy Policy
  • Terms & Conditions
  • Contact
  • Advertise

RegStream Media Group © 2026. All Rights Reserved